CAT upholds £62m Pfizer fine for gouging NHSE with ‘unfair’ epilepsy pill prices
An appeal tribunal has upheld almost £70m in fines for two companies’ “illegal behaviour” that upped NHS spending on phenytoin sodium capsules by £48m in a year.
An appeal tribunal has upheld almost £70m in fines for two companies’ “illegal behaviour” that upped NHS spending on phenytoin sodium capsules by £48m in a year.
